KNG1 and diabetes mellitus: These findings imply that small differences might exist between ACEIs and ARBs for patients with diabetes, and ACEIs might provide additional renoprotective effects through the elevation in bradykinin as well as the activation of B2-type bradykinin receptors [38, 39].